10-K: XWELL Inc. Files 10-K Report, Details Financial Performance and Strategic Shifts
Annual Results
XWELL Inc.'s 10-K filing reveals a significant revenue decrease due to the decline of its XpresTest segment, alongside strategic moves to expand its wellness services beyond airports.
Summary
- XWELL Inc. reported a 46% decrease in total revenue, primarily due to the closure of XpresCheck locations as COVID-19 testing demand declined.
- The company experienced a reduction in cost of sales, depreciation, and general and administrative expenses, reflecting cost-cutting measures.
- Impairment charges were recorded for goodwill, intangible assets, and long-lived assets, totaling approximately $8.877 million.
- The company acquired Naples Wax Center for $1.624 million, aiming to expand its wellness platform beyond airports.
- XWELL is focusing on expanding its retail strategy and health and wellness services outside of airports, including a new TreatStudios concept.
- The company's strategy includes right-sizing its airport portfolio, international expansion, and acquisitions to drive future growth.
- As of December 31, 2023, XWELL had approximately $8.437 million in cash and cash equivalents and $14.613 million in marketable securities.
- The company reported a net loss of $27.741 million attributable to XWELL Inc. for the year ended December 31, 2023.
Sentiment
Score: 4
Explanation: The document presents a mixed picture. While there are strategic moves for future growth, the significant revenue decline, impairment charges, and material weaknesses in internal controls raise concerns. The company's need for additional funding and the potential for a reverse stock split also contribute to a negative sentiment.
Positives
- The company is actively expanding its retail strategy and aligning products with service offerings.
- XWELL is diversifying its business by expanding outside of airports, including into transit centers and through acquisitions.
- The company is implementing an international expansion plan to capitalize on the return of international travel.
- XWELL is optimizing its cost structure and right-sizing its existing business to improve profitability.
- The company has a strong cash position with $8.437 million in cash and cash equivalents and $14.613 million in marketable securities as of December 31, 2023.
Negatives
- The company experienced a significant decrease in revenue due to the decline of the XpresTest segment.
- XWELL recorded substantial impairment charges, indicating a decrease in the value of certain assets.
- The company identified material weaknesses in its internal controls over financial reporting.
- The company has a history of net losses and may require additional funding to fully realize its business plan.
- The company's stock price has been volatile and may be subject to further fluctuations.
Risks
- The company's business is subject to various risks, including economic downturns, inflation, and changes in consumer spending.
- XWELL relies on international and domestic airplane travel, and a decrease in travel would negatively impact its operations.
- The company depends on third parties for critical services and is subject to risks related to their compliance with laws and regulations.
- XWELL must comply with complex and overlapping laws protecting the privacy and security of health information and personal data.
- The company's expansion into new markets may present increased risks due to unfamiliarity with those areas.
- Failure to comply with minimum airport concession disadvantaged business enterprise participation goals could lead to lost business opportunities.
- The company may not be able to execute its growth strategy or integrate new acquisitions successfully.
- The company's stock price is volatile and may be depressed by various factors, including failure to meet financial guidance.
- The company has identified material weaknesses in its internal controls over financial reporting, which could impair its ability to produce accurate financial statements.
Future Outlook
XWELL believes it is well-positioned to benefit from growing consumer interest in travel health and wellness. The company's go-forward plan includes expanding and integrating products and services across its brands, right-sizing its airport portfolio, executing an off-airport strategy through acquisitions, implementing an international expansion plan, and scaling growth responsibly to drive shareholder value.
Management Comments
- Management believes that the company is well positioned to benefit from consumers growing interest and pent-up demand in travel health and wellness.
- Management is focused on right-sizing the existing business, optimizing the cost structure, and making acquisitions that further leverage the strength of the brand portfolio.
- Management is looking to further expand internationally, taking advantage of the current market to grow.
Industry Context
The document highlights the shift in airport retail from traditional food and beverage to wellness services, positioning XWELL to capitalize on this trend. The company's flexible retail format and footprint within airports are also noted as advantages. The acquisition of Naples Wax Center and the development of TreatStudios indicate a move to diversify beyond airport locations, aligning with a broader trend of wellness services expanding into various transit and community centers.
Comparison to Industry Standards
- The document mentions that the largest domestic competitor operates 14 locations in 9 airports, while XWELL operates 21 domestic locations and 11 international locations, indicating a larger footprint.
- XWELL's flexible retail format, ranging from 200 to 2,600 square feet, allows it to adapt to space-constrained airports, which is a competitive advantage compared to other retail concepts.
- The company's focus on health and wellness services in airports aligns with a growing trend in the travel industry, where airports are increasingly seeking to offer unique and health-focused services to travelers.
- The acquisition of Naples Wax Center and the development of TreatStudios are strategic moves to diversify beyond airport locations, which is a common strategy for companies in the wellness and retail sectors to reduce reliance on a single market.
Legal Proceedings
- The company is involved in a lawsuit filed by OTG Management at Philadelphia International Airport, claiming that XWELL improperly backed out of its sublease for space at Terminal B and now owes between $865 and $2,250 in accelerated rent for the 12-year contract.
Stakeholder Impact
- Shareholders may be concerned about the company's financial performance and the need for additional funding.
- Employees may be affected by headcount reductions and changes in the company's strategy.
- Customers may benefit from the expansion of wellness services and products.
- Suppliers and creditors may be impacted by the company's financial performance and strategic shifts.
Next Steps
- The company will continue to expand and integrate products and services across its six brands.
- XWELL will focus on right-sizing its existing airport portfolio to a leaner and more profitable business.
- The company will execute an off-airport strategy through acquisition to deliver more products and services.
- XWELL will implement an international expansion plan.
- The company will ensure it can scale its growth in a responsible way that drives shareholder value.
- The company plans to open its first TreatStudios location in Jacksonville, Florida in 2024.
Key Dates
| Date | Description |
|---|---|
| January 8, 2018 | XpresSpa Group, Inc. common stock listed under the trading symbol XSPA on the Nasdaq Capital Market. |
| October 24, 2022 | Company filed an amended and restated certificate of incorporation with the Delaware Secretary of State reflecting the name change to XWELL, Inc. |
| October 25, 2022 | Company changed its name to XWELL, Inc. and common stock began trading under the symbol XWEL. |
| September 12, 2023 | XWELL acquired Naples Wax, LLC. |
| September 28, 2023 | Company effected a 1-for-20 reverse stock split. |
| December 31, 2023 | End of fiscal year 2023. |
| April 15, 2024 | 4,183,435 shares of the company's common stock are outstanding. |
| April 16, 2024 | Date of the 10-K filing. |
Keywords
wellness, travel, airport, spa, testing, XpresSpa, XpresTest, Naples Wax Center, Treat, retail, acquisitions, international expansion, bio surveillance, financial reporting, internal controls
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.